↓ Skip to main content

Cell-Free Glycoengineering of the Recombinant SARS-CoV-2 Spike Glycoprotein

Overview of attention for article published in Frontiers in Bioengineering and Biotechnology, August 2021
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (60th percentile)
  • High Attention Score compared to outputs of the same age and source (85th percentile)

Mentioned by

twitter
5 X users

Citations

dimensions_citation
5 Dimensions

Readers on

mendeley
42 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Cell-Free Glycoengineering of the Recombinant SARS-CoV-2 Spike Glycoprotein
Published in
Frontiers in Bioengineering and Biotechnology, August 2021
DOI 10.3389/fbioe.2021.699025
Pubmed ID
Authors

Johannes Ruhnau, Valerian Grote, Mariana Juarez-Osorio, Dunja Bruder, Reza Mahour, Erdmann Rapp, Thomas F. T. Rexer, Udo Reichl

X Demographics

X Demographics

The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 42 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 42 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 5 12%
Student > Ph. D. Student 5 12%
Researcher 4 10%
Student > Master 4 10%
Student > Postgraduate 3 7%
Other 4 10%
Unknown 17 40%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 9 21%
Chemistry 4 10%
Agricultural and Biological Sciences 4 10%
Chemical Engineering 3 7%
Pharmacology, Toxicology and Pharmaceutical Science 1 2%
Other 3 7%
Unknown 18 43%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 11 February 2023.
All research outputs
#12,939,149
of 23,332,901 outputs
Outputs from Frontiers in Bioengineering and Biotechnology
#1,382
of 6,973 outputs
Outputs of similar age
#154,179
of 400,603 outputs
Outputs of similar age from Frontiers in Bioengineering and Biotechnology
#45
of 313 outputs
Altmetric has tracked 23,332,901 research outputs across all sources so far. This one is in the 44th percentile – i.e., 44% of other outputs scored the same or lower than it.
So far Altmetric has tracked 6,973 research outputs from this source. They receive a mean Attention Score of 3.6. This one has done well, scoring higher than 79% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 400,603 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 60% of its contemporaries.
We're also able to compare this research output to 313 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 85% of its contemporaries.